CMS Open Payments · Program Year 2024
Hubly Incorporated
Hubly Incorporated reported $30,455.53 across General Payments, Research, and Ownership to 4 physicians and teaching hospitals across 9 transactions.
- $30.5K Below-median payer
- All-tracks total
- 9 Below-median volume
- Transactions
- 4 Below-median reach
- Recipients
- #1467
- of 1,925 companies
Hubly Incorporated reported $30,455.53 across all CMS Open Payments tracks (General + Research + Ownership) to 4 physicians and teaching hospitals in Program Year 2024 - ranking #1467 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $205.53, averaging $7.6K per recipient.
How Hubly Incorporated's $30.5K all-tracks total breaks down
Hubly Incorporated's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
10/100
Total payments
F
10/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
10/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer hubly-incorporated Hubly Incorporated
$30.5K · #1467/1,925 · 0.0% industry · PY2024
- TOT $30.5K
- RANK #1467
- SHARE 0.0%
- TXN 9
- RCP 4
- CAT 1
- GEN $205.53
- TOP1 70.5%
- PY 2024
Volume peers
Nearest volume peer: Molli Surgical (us) Inc ($30.6K)
Hubly Incorporated sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Hubly Incorporated
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Hubly Incorporated, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
Of the 1 general-payment categories charted below, "Food and Beverage" is the largest at $205.53 across 4 transactions, 100.0% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
"Food and Beverage" leads Hubly Incorporated's 1-category general-payment breakdown at $205.53, 100.0% of the reported total.
How Hubly Incorporated divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $205.53 | 4 | 100.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $205.53 (100.0%) of $205.53 in this company's General Payments records across 2 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Hubly Incorporated
The five named recipients with the highest reported General Payments from this company
- 1
Nitesh Patel
$144.85 across 2 reported transactions
- 2
Jesse Kong
$60.68 across 2 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Hubly Incorporated ranks #1467 of 1,925 by total payments (bottom 24% by spend) but is notably more concentrated than that alone would suggest -- #274 of 1,838 by HHI (top 15% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- Vertical Orthopaedics, Inc. : $34.2K total payments, HHI 5923
- TheraMicro, Inc. : $14.0K total payments, HHI 5918
- ReShape Lifesciences Inc. : $5.8K total payments, HHI 5891
- Rebiotix Inc. : $114.1K total payments, HHI 5889
- Spark Therapeutics, Inc. : $1.1M total payments, HHI 5876
- Agile Devices, Inc. : $8.4K total payments, HHI 5847
- Hubly Incorporated (this company) : $205.53 total payments, HHI 5839
- New York Blood Center, Inc. : $184.6K total payments, HHI 5838
- Mylan Pharmaceuticals Inc. : $379.70 total payments, HHI 5777
- Novo Nordisk US Research & Development, Inc. : $7.8K total payments, HHI 5774
- Spinevision SAS : $66.0K total payments, HHI 5765
- Cook Medical LLC : $2.8M total payments, HHI 5718
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Hubly Incorporated's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Hubly Incorporated.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Hubly Incorporated.
Showing 6 of 1,924 companies with CMS-reported payment data.
Intelivation Technologies, LLC
McKesson Drug Company LLC
RIWOspine, Inc.
Jubilant Therapeutics Inc
Surgical Fusion Inc.
Put this to use
Hubly Incorporated ranks #1467 of 1,925 by all-tracks total payments, led by "Food and Beverage".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Food and Beverage" spend across every manufacturer, not just Hubly Incorporated. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.